| Fri, 19 Oct 2018 12:25:44: | Midphase MM-121 fail continues Merrimack’s losing streak
|
| Fri, 19 Oct 2018 12:14:21: | ESMO: Deciphera's new data backs profile of DCC-2618 in GIST
|
| Fri, 19 Oct 2018 11:53:37: | Intellia's gene-editing ATTR treatment cuts abnormal proteins in monkeys
|
| Fri, 19 Oct 2018 11:42:58: | Parker Institute teams up with Xyphos to tame CAR-Ts
|
| Thu, 18 Oct 2018 17:28:23: | Chutes & Ladders—Merck beefs up digital team with Nike executive
|
| Thu, 18 Oct 2018 13:59:55: | Ziopharm’s R&D head joins Spectrum as CMO
|
| Thu, 18 Oct 2018 10:38:27: | Gilead, Aelix ally to trial HIV-suppressing combination
|
| Thu, 18 Oct 2018 09:55:05: | Novartis inks $2.1B Endocyte buyout, furthering radiotherapy push
|
| Thu, 18 Oct 2018 09:48:39: | 3D human neural network could aid studies in brain diseases
|
| Thu, 18 Oct 2018 08:49:18: | Afferent executives launch next-generation neuro hopeful, gaining Johnson & Johnson backing
|
| Wed, 17 Oct 2018 21:42:54: | TP Therapeutics raises $80M as CMO Countouriotis takes the helm
|
| Wed, 17 Oct 2018 20:02:10: | Johnson & Johnson takes $630M hit on RSV drug bought with Alios
|
| Wed, 17 Oct 2018 12:39:39: | Eiger chalks up one win, one loss in rare disease pipeline
|
| Wed, 17 Oct 2018 12:24:07: | Roche sheds clutch of in-licensed drugs in pipeline cull
|
| Wed, 17 Oct 2018 11:57:34: | Pharnext muscle wasting phase 3 hits primary endpoint
|
| Wed, 17 Oct 2018 10:07:14: | Improving cancer immunotherapy by controlling RNA expression
|
| Tue, 16 Oct 2018 17:55:07: | ICER weighs plan to offer trial design advice to pharma companies, for a price
|
| Tue, 16 Oct 2018 13:14:17: | As U.K. politicians fret Brexit will ‘decimate medical research,’ AstraZeneca sticks to R&D plan
|
| Tue, 16 Oct 2018 12:28:12: | Nearing phase 3, resTORbio posts new data on infection drug
|
| Tue, 16 Oct 2018 12:21:33: | Seeking global deals, Taiho swells its U.S.-based VC fund to $300M
|
| Mon, 15 Oct 2018 21:22:53: | Revolution Medicines to absorb Warp Drive Bio into its oncology and ‘undruggable’ discovery efforts
|
| Mon, 15 Oct 2018 13:09:39: | F-star names ex-Immunocore CEO Eliot Forster as leader
|
| Mon, 15 Oct 2018 13:09:02: | Australian team discovers how one orderly protein protects against cancer
|
| Mon, 15 Oct 2018 12:53:50: | HiFiBiO buys up H-Immune, joining forces to ‘combat cancer’
|
| Mon, 15 Oct 2018 12:38:20: | Alnylam drops early filing plan for porphyria drug givosiran
|
